Synthesis, SAR and biological evaluation of 1,6-disubstituted-1H-pyrazolo[3,4-d]pyrimidines as dual inhibitors of Aurora kinases and CDK1
Authors:
- Jean-Yves Le BrazidecJBJean-Yves Le Brazidec
- Angela PasisAPAngela Pasis
- Betty TamBTBetty Tam
- Christina BoykinCBChristina Boykin
- Cheryl BlackCBCheryl Black
- Deping WangDWDeping Wang
- Gisela ClaassenGCGisela Claassen
- Jer-Hong ChongJCJer-Hong Chong
- Jianhua ChaoJCJianhua Chao
- Junhua FanJFJunhua Fan
- Khanh NguyenKNKhanh Nguyen
- Laura SilvianLSLaura Silvian
- 1 March 2012
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 22 (5) , 2070-2074
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I)Bioorganic & Medicinal Chemistry Letters, 2011
- Aurora kinase inhibitorsCritical Reviews in Oncology/Hematology, 2010
- Cell cycle kinases as therapeutic targets for cancerNature Reviews Drug Discovery, 2009
- The influence of drug-like concepts on decision-making in medicinal chemistryNature Reviews Drug Discovery, 2007
- Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinaseProceedings of the National Academy of Sciences, 2007
- The In vitro and In vivo Effects of JNJ-7706621: A Dual Inhibitor of Cyclin-Dependent Kinases and Aurora KinasesCancer Research, 2005
- Aurora kinases: shining lights on the therapeutic horizon?Oncogene, 2005
- Mechanism of Aurora B Activation by INCENP and Inhibition by HesperadinMolecular Cell, 2005
- Structural Basis of Aurora-A Activation by TPX2 at the Mitotic SpindleMolecular Cell, 2003
- Crystal Structure of Aurora-2, an Oncogenic Serine/Threonine KinaseJournal of Biological Chemistry, 2002